Patents Assigned to Wuhan Institute of Virology, CAS
  • and double transgenic mouse and its construction methods
    Patent number: 9510570
    Abstract: The present invention provides a CD81 and OCLN double transgenic mouse and its construction method and use. The double transgenic mouse can be used to constitute acute and chronic HCV infection in a mouse model.
    Type: Grant
    Filed: June 24, 2014
    Date of Patent: December 6, 2016
    Assignee: Wuhan Institute of Virology, CAS
    Inventors: Hong Tang, Xin-Wen Chen, Ji-Zheng Chen, Yang Zhao, Chao Zhang, Hai-Rong Chen